Cargando…

Developing a risk prediction model for multidrug-resistant bacterial infection in patients with biliary tract infection

BACKGROUND/AIMS: The aim of this study was to develop a tool to predict multidrug-resistant bacteria infections among patients with biliary tract infection for targeted therapy. PATIENTS AND METHODS: We conducted a single-center retrospective descriptive study from January 2016 to December 2018. Uni...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Yingying, Lin, Kongying, Lin, Kecan, Lin, Haitao, Chen, Ruijia, Li, Shengcong, Wang, Jinye, Zeng, Yongyi, Liu, Jingfeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8019140/
https://www.ncbi.nlm.nih.gov/pubmed/32769261
http://dx.doi.org/10.4103/sjg.SJG_128_20
_version_ 1783674321225383936
author Hu, Yingying
Lin, Kongying
Lin, Kecan
Lin, Haitao
Chen, Ruijia
Li, Shengcong
Wang, Jinye
Zeng, Yongyi
Liu, Jingfeng
author_facet Hu, Yingying
Lin, Kongying
Lin, Kecan
Lin, Haitao
Chen, Ruijia
Li, Shengcong
Wang, Jinye
Zeng, Yongyi
Liu, Jingfeng
author_sort Hu, Yingying
collection PubMed
description BACKGROUND/AIMS: The aim of this study was to develop a tool to predict multidrug-resistant bacteria infections among patients with biliary tract infection for targeted therapy. PATIENTS AND METHODS: We conducted a single-center retrospective descriptive study from January 2016 to December 2018. Univariate and multivariable logistic regression analysis were used to identify independent risk factors of multidrug-resistant bacterial infections. A nomogram was constructed according to multivariable regression model. Moreover, the clinical usefulness of the nomogram was estimated by decision curve analysis. RESULTS: 121 inpatients were randomly divided into a training cohort (n = 79) and validation cohort (n = 42). In multivariate analysis, 5 factors were associated with biliary tract infections caused by multidrug-resistant bacterial infections: aspartate aminotransferase (Odds ratio (OR), 13.771; 95% confidence interval (CI), 3.747-64.958; P < 0.001), previous antibiotic use within 90 days (OR, 4.130; 95% CI, 1.192-16.471; P = 0.032), absolute neutrophil count (OR, 3.491; 95% CI, 1.066-12.851; P = 0.046), previous biliary surgery (OR, 3.303; 95% CI, 0.910-13.614; P = 0.079), and hemoglobin (OR, 0.146; 95% CI, 0.030-0.576; P = 0.009). The nomogram model was constructed based on these variables, and showed good calibration and discrimination in the training set [area under the curve (AUC), 0.86] and in the validation set (AUC, 0.799). The decision curve analysis demonstrated the clinical usefulness of our nomogram. Using the nomogram score, high risk and low risk patients with multidrug-resistant bacterial infection could be differentiated. CONCLUSIONS: This simple bedside prediction tool to predict multidrug-resistant bacterial infection can help clinicians identify low versus high risk patients as well as choose appropriate, timely initial empirical antibiotics therapy. This model should be validated before it is widely applied in clinical settings.
format Online
Article
Text
id pubmed-8019140
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-80191402021-04-05 Developing a risk prediction model for multidrug-resistant bacterial infection in patients with biliary tract infection Hu, Yingying Lin, Kongying Lin, Kecan Lin, Haitao Chen, Ruijia Li, Shengcong Wang, Jinye Zeng, Yongyi Liu, Jingfeng Saudi J Gastroenterol Original Article BACKGROUND/AIMS: The aim of this study was to develop a tool to predict multidrug-resistant bacteria infections among patients with biliary tract infection for targeted therapy. PATIENTS AND METHODS: We conducted a single-center retrospective descriptive study from January 2016 to December 2018. Univariate and multivariable logistic regression analysis were used to identify independent risk factors of multidrug-resistant bacterial infections. A nomogram was constructed according to multivariable regression model. Moreover, the clinical usefulness of the nomogram was estimated by decision curve analysis. RESULTS: 121 inpatients were randomly divided into a training cohort (n = 79) and validation cohort (n = 42). In multivariate analysis, 5 factors were associated with biliary tract infections caused by multidrug-resistant bacterial infections: aspartate aminotransferase (Odds ratio (OR), 13.771; 95% confidence interval (CI), 3.747-64.958; P < 0.001), previous antibiotic use within 90 days (OR, 4.130; 95% CI, 1.192-16.471; P = 0.032), absolute neutrophil count (OR, 3.491; 95% CI, 1.066-12.851; P = 0.046), previous biliary surgery (OR, 3.303; 95% CI, 0.910-13.614; P = 0.079), and hemoglobin (OR, 0.146; 95% CI, 0.030-0.576; P = 0.009). The nomogram model was constructed based on these variables, and showed good calibration and discrimination in the training set [area under the curve (AUC), 0.86] and in the validation set (AUC, 0.799). The decision curve analysis demonstrated the clinical usefulness of our nomogram. Using the nomogram score, high risk and low risk patients with multidrug-resistant bacterial infection could be differentiated. CONCLUSIONS: This simple bedside prediction tool to predict multidrug-resistant bacterial infection can help clinicians identify low versus high risk patients as well as choose appropriate, timely initial empirical antibiotics therapy. This model should be validated before it is widely applied in clinical settings. Wolters Kluwer - Medknow 2020-08-08 /pmc/articles/PMC8019140/ /pubmed/32769261 http://dx.doi.org/10.4103/sjg.SJG_128_20 Text en Copyright: © 2020 Saudi Journal of Gastroenterology http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Original Article
Hu, Yingying
Lin, Kongying
Lin, Kecan
Lin, Haitao
Chen, Ruijia
Li, Shengcong
Wang, Jinye
Zeng, Yongyi
Liu, Jingfeng
Developing a risk prediction model for multidrug-resistant bacterial infection in patients with biliary tract infection
title Developing a risk prediction model for multidrug-resistant bacterial infection in patients with biliary tract infection
title_full Developing a risk prediction model for multidrug-resistant bacterial infection in patients with biliary tract infection
title_fullStr Developing a risk prediction model for multidrug-resistant bacterial infection in patients with biliary tract infection
title_full_unstemmed Developing a risk prediction model for multidrug-resistant bacterial infection in patients with biliary tract infection
title_short Developing a risk prediction model for multidrug-resistant bacterial infection in patients with biliary tract infection
title_sort developing a risk prediction model for multidrug-resistant bacterial infection in patients with biliary tract infection
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8019140/
https://www.ncbi.nlm.nih.gov/pubmed/32769261
http://dx.doi.org/10.4103/sjg.SJG_128_20
work_keys_str_mv AT huyingying developingariskpredictionmodelformultidrugresistantbacterialinfectioninpatientswithbiliarytractinfection
AT linkongying developingariskpredictionmodelformultidrugresistantbacterialinfectioninpatientswithbiliarytractinfection
AT linkecan developingariskpredictionmodelformultidrugresistantbacterialinfectioninpatientswithbiliarytractinfection
AT linhaitao developingariskpredictionmodelformultidrugresistantbacterialinfectioninpatientswithbiliarytractinfection
AT chenruijia developingariskpredictionmodelformultidrugresistantbacterialinfectioninpatientswithbiliarytractinfection
AT lishengcong developingariskpredictionmodelformultidrugresistantbacterialinfectioninpatientswithbiliarytractinfection
AT wangjinye developingariskpredictionmodelformultidrugresistantbacterialinfectioninpatientswithbiliarytractinfection
AT zengyongyi developingariskpredictionmodelformultidrugresistantbacterialinfectioninpatientswithbiliarytractinfection
AT liujingfeng developingariskpredictionmodelformultidrugresistantbacterialinfectioninpatientswithbiliarytractinfection